Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

World Rank (Jan-05-2024)
8,543
Market Cap (Jan-05-2024)
1.007 Billion USD
World Rank (Jul-30-2023)
9,414
Market Cap (Jul-30-2023)
0.876 Billion USD
World Rank (Jan-07-2022)
10,439
Market Cap (Jan-07-2022)
0.828 Billion USD
World Rank (Jan-01-2021)
7,911
Market Cap (Jan-01-2021)
1.010 Billion USD
Headquarters Country
Sweden
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
24 Million USD
Annual Net Income in USD
1 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
145 Million USD
Total Liabilities in USD
24 Million USD
Total Equity in USD
121 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
Company Website
XVIVO PERFUSION AB (PUBL)
Yahoo
Yahoo @ Stockholm
Company Profile
Xvivo Perfusion AB (publ) is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. The company annual revenue is 179.8 million SEK and total assets are 1,150 million SEK as on 2020. The headquarters is in Sweden.
ISIN Code
SE0004840718
Stock Exchange
Stockholm
Company SubCategory
Top Healthcare Companies in Europe

Share